Literature DB >> 9520090

Establishment and characterization of a new hamster pancreatic cancer cell line: the biological activity and the binding characteristics of EGF or TGF-alpha.

Y Morita1, T Moriai, Y Takiyama, I Makino.   

Abstract

CONCLUSIONS: This new animal cell line may be a useful model to study the effect of growth factors on malignant cell proliferation and differentiation in both in vivo and in vitro systems.
METHODS: We established a new pancreatic cancer cell line from pancreatic cancer in the hamster (HPC) induced by N-nitrosobis(2-oxopropyl)amine (BOP) and characterized its morphological, pathological, and biological patterns.
RESULTS: Cells grew rapidly, with a doubling time of 22.5 h. Chromosome number ranged from 33 to 144, and flow cytometric analysis showed two peaks of DNA distribution as a proliferative pattern. Ultrastructural analyses using transmission and scanning electron microscopy of HPC cells revealed desmosomes and loose interdigitation, with pseudopods and microvilli on the cell surface. The overexpression of epidermal growth factor (EGF) receptors on HPC cells was shown by immunohistochemistry. Binding characteristics and biological activity of EGF and type alpha transforming growth factor (TGF-alpha) were studied. TGF-alpha stimulated DNA synthesis in a dose-dependent manner, whereas EGF was without effect. Scatchard analysis of 125I-EGF binding data at pH 7.4 indicated the presence of two orders of binding sites, where that of 125I-TGF-alpha showed only a single order. Regarding the effect of pH on 125I-EGF or 125I-TGF-alpha dissociation, one-half maximal dissociation of 125I-EGF or 125I-TGF-alpha occurred at pH 6.0 or 6.5, respectively. Characteristics of the EGF receptor are similar to those of cultured human pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520090     DOI: 10.1007/BF02787502

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  23 in total

1.  Surgical treatment of pancreatic cancer. The United States experience.

Authors:  E H Livingston; M L Welton; H A Reber
Journal:  Int J Pancreatol       Date:  1991

2.  Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid.

Authors:  J J Ryan; I D Hay; C S Grant; L M Rainwater; G M Farrow; J R Goellner
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

3.  Metastatic capacity and intercellular communication between normal cells and metastatic cell clones derived from a rat mammary carcinoma.

Authors:  J Hamada; N Takeichi; H Kobayashi
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

4.  Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

Authors:  J J Smith; R Derynck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens.

Authors:  H Egami; Y Takiyama; M Cano; W H Houser; P M Pour
Journal:  Carcinogenesis       Date:  1989-05       Impact factor: 4.944

7.  Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma.

Authors:  E Borgström; B Wahren
Journal:  Cancer       Date:  1986-12-01       Impact factor: 6.860

8.  A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.

Authors:  T Moriai; M S Kobrin; C Hope; L Speck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

9.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

10.  Surgical treatment of pancreatic cancer. The Japanese experience.

Authors:  T Nagakawa; I Konishi; K Ueno; T Ohta; T Akiyama; M Kayahara; I Miyazaki
Journal:  Int J Pancreatol       Date:  1991
View more
  1 in total

Review 1.  Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer.

Authors:  J D Liao; N V Adsay; F Khannani; D Grignon; A Thakur; F H Sarkar
Journal:  Histol Histopathol       Date:  2007-06       Impact factor: 2.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.